JP Patent

JP7109189B2 — シクロペプチド系化合物の組成物およびその製造方法と使用

Assigned to Shanghai Techwell Biopharmaceutical Co Ltd · Expires 2022-07-29 · 4y expired

What this patent protects

Patent listed against bendamustine-hydrochloride.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP7109189B2
Jurisdiction: JP
Classification: —
Expires: 2022-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Techwell Biopharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.